This page keeps track of new/upcoming treatment options for Crohn’s disease. What’s in development? What’s promising? What’s available soon? Find out below… Current topics include Fn14 antagonists, TWEAK, gut microbiome, fecal microbial transplant (FMT), gene therapy, and more. Subscribe to Email Updates
Last updated:
March 26, 2020
News
- Mount Sinai researchers unveil mechanisms to prevent Crohn’s disease Mar 26, 2020
- Janssen’s Stelara Sees Positive Results in Crohn’s Disease Study Feb 14, 2020
- Alpine Immune Sciences Presents New Preclinical Data at 2020 Crohn’s & Colitis Congress: ALPN-101 demonstrates efficacy in treatment of chronic inflammatory bowel disease in both in vivo and in vitro models Jan 24, 2020
- 5 major advances in inflammatory bowel disease (IBD) treatment Jan 23, 2020
- Mayo Clinic, maker of Gore-Tex outerwear are teaming up in Crohn’s fight: new venture hopes to market promising stem cell therapy for Crohn’s disease Dec 10, 2019
- An Engineered Probiotic Could Be a Novel Treatment Avenue for Inflammatory Bowel Disease Dec 9, 2019
- Empowering mucosal healing with an engineered probiotic Dec 6, 2019
- Drug decreases gut leakiness associated with ulcerative colitis Dec 4, 2019
- Finch Therapeutics & Takeda Expand Collaboration to Develop Microbiome Therapeutics for Crohn’s Disease Nov 13, 2019
- Immune system pathway may be key to Crohn’s disease treatment Aug 19, 2019
Research
Clinical Trials
- Low Dose IL-2 for the Treatment of Crohn’s Disease Feb 11, 2020
